SBRA Sabra Health Care REIT, Inc.
Real Estate Investment Trusts · Nasdaq · SEC CIK 1492298 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $249.56M | $235.87M | $221.75M | $211.90M | $190.04M | $189.15M | $183.54M | $182.35M |
| SG&A expense | $15.58M | $16.82M | $14.86M | $15.91M | $12.56M | $12.51M | $12.73M | $13.03M |
| Interest expense | $29.16M | $29.78M | $28.41M | $28.94M | $28.90M | $27.55M | $27.10M | $28.08M |
| Pretax income | $26.40M | -$26.79M | $39.43M | $25.99M | $21.73M | $65.21M | $40.50M | $47.17M |
| Income tax | $71,000 | $678,000 | $526,000 | $491,000 | $436,000 | $497,000 | $413,000 | $380,000 |
| Net income | $28.61M | -$25.20M | $40.88M | $27.23M | $22.54M | $65.54M | $40.30M | $46.70M |
| EPS (basic) | 0.11 | -0.10 | 0.16 | — | 0.09 | 0.28 | 0.17 | — |
| EPS (diluted) | 0.11 | -0.10 | 0.16 | — | 0.09 | 0.27 | 0.17 | — |
| Dividends declared per share | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 |
| Weighted avg. shares (diluted) | 259.82M | 252.27M | 255.97M | — | 243.56M | 240.93M | 240.30M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $36.24M | $231.58M | $116.53M | $71.54M | $207.52M | $101.65M | $28.90M | $66.34M |
| Intangibles | $87.18M | $82.95M | $67.41M | $65.32M | $59.81M | $24.65M | $24.82M | $27.46M |
| Total assets | $5.43B | $5.51B | $5.59B | $5.49B | $5.56B | $5.33B | $5.23B | $5.30B |
| Long-term debt | $2.44B | $2.63B | $2.67B | $2.53B | $2.59B | $2.48B | $2.39B | $2.42B |
| Total debt | $2.44B | $2.63B | $2.67B | $2.53B | $2.59B | $2.48B | $2.39B | $2.42B |
| Total liabilities | $2.59B | $2.76B | $2.80B | $2.67B | $2.74B | $2.62B | $2.53B | $2.56B |
| Shareholders' equity | $2.84B | $2.75B | $2.79B | $2.82B | $2.82B | $2.71B | $2.70B | $2.74B |
| Net debt | $2.40B | $2.39B | $2.55B | $2.46B | $2.38B | $2.38B | $2.37B | $2.35B |
| Shares outstanding | 261.96M | 255.46M | 252.19M | 251.70M | 249.35M | 239.79M | 237.94M | 237.59M |
| Cash flow statement | ||||||||
| Operating cash flow | $128.97M | $85.82M | $98.36M | $87.43M | $99.96M | $80.96M | $80.26M | $79.97M |
| Investing cash flow | -$171.85M | $86.50M | -$105.09M | -$116.55M | -$199.84M | -$45.13M | -$16.44M | $18.56M |
| Financing cash flow | -$152.25M | -$57.36M | $52.10M | -$100.89M | $206.17M | $36.73M | -$101.24M | -$100.96M |
| Depreciation & amortization | $64.78M | $56.38M | $53.13M | $51.41M | $48.51M | $43.59M | $43.49M | $42.31M |
| Stock-based compensation | $3.92M | $4.09M | $3.10M | $3.07M | $2.88M | $2.70M | $2.71M | $2.54M |
| Dividends paid | $76.64M | $75.66M | $75.66M | $74.81M | $71.94M | $71.38M | $71.37M | $70.98M |
Free plan shows the latest 8 periods; Pro shows all 63 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.